#takeda — Public Fediverse posts

BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks

🔗 Full Story: https://www.talknation.site/2026/02/assessing-takeda-pharmaceutical-tse4502.html

#news #tech #talknation

Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. https://www.japantimes.co.jp/business/2025/11/04/companies/takeda-dengue-vaccine/?utm_medium=Social&utm_source=mastodon #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations

タケダのワクチンへの取り組み　新型コロナワクチンの情報は「コロナ情報館」｜武田薬品工業株式会社【公式】 https://www.yayafa.com/2568162/ #biopharmaceutical #business #Future #global #Health #Introduction #Medicine #Mission #People #pharmaceutical #Philosophy #Rd #Takeda #TakedaIsm #values #Vision #新型コロナウイルスで

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings

Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster—GLP-1s may cut risk of 10 obesity-related cancers in diabetics —Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births —http://bit.ly/w28kSd #mergersandacquistions #elililly #ibd #takeda #glp1 #novonordisk #diabetes #cancer #pfizer #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --http://bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

@faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.